Skip to main content
PALX
OTC Technology

Palomino Labs Reports Q1 Losses, Secures $17M in New Funding

feedReported by Wiseek News
Sentiment info
Neutral
Importance info
8
Price
0
Mkt Cap
0
52W Low
0
52W High
0
Market data snapshot near publication time

summarizeSummary

Palomino Laboratories Inc. reported its first-quarter 2026 results, showing no revenue and a net loss of $1.24 million, or $(0.07) diluted EPS. While the company remains in a development stage with ongoing losses, a significant private placement completed in April 2026 raised $16.98 million. This capital infusion is critical, providing the company with sufficient funding to cover operations for at least one year. The financing addresses immediate liquidity concerns for the recently public company, allowing it to continue advancing its microLED optoelectronic platform and R&D efforts.

This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed PALX - Latest Insights

PALX
May 15, 2026, 3:51 PM EDT
Source: Wiseek News
Importance Score:
8